In addition, mouse models elucidate the oncogenic function of linc‐ZNF25‐1 and the enhanced therapeutic effect of asparaginase (L‐ASNase) in combination with GEM in pancreatic cancer. This evidence concerns the gene ZNF251 and familial pancreatic carcinoma.